Reflect on the provided data and tweets to anticipate if the closing price of $jnj is going to increase or decrease at 2017-02-23. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-08,-0.1,0.3,-0.2,-0.1,-0.1,0.1,-0.1,-0.1,0.2,0.7,0.9
2017-02-09,-0.6,0.5,-0.6,0.6,0.6,-0.4,-0.5,-0.7,-0.4,0.0,0.2
2017-02-10,-0.8,0.7,-0.9,1.0,1.0,-1.1,-1.4,-1.6,-1.4,-1.1,-0.8
2017-02-13,-0.5,0.2,-0.6,0.6,0.6,-1.3,-1.7,-2.1,-1.9,-1.6,-1.3
2017-02-14,-0.8,0.0,-0.9,0.4,0.4,-1.2,-1.8,-2.2,-2.2,-2.0,-1.7
2017-02-15,-1.1,0.2,-1.4,0.7,0.7,-1.2,-2.2,-2.7,-2.8,-2.7,-2.4
2017-02-16,-0.9,0.2,-0.9,0.8,0.8,-1.3,-2.5,-3.0,-3.4,-3.3,-3.0
2017-02-17,-0.6,0.0,-0.7,0.7,0.7,-1.3,-2.7,-3.4,-3.8,-3.8,-3.6
2017-02-21,-1.1,0.2,-1.1,0.7,0.7,-1.4,-2.9,-3.7,-4.2,-4.3,-4.2
2017-02-22,-0.2,0.2,-0.2,-0.1,-0.1,-0.7,-2.3,-3.2,-3.8,-4.0,-4.0

2017-02-08: johnson &amp; johnson $jnj position cut by orgel wealth management llc |johnson &amp; johnson $jnj position cut by orgel wealth management llc |allen investment management llc acquires 19 shares of jo
2017-02-09: #johnsonjohnson rinse-off skin care composition with cellulosic materials patented by j&amp;j. read more:  $jnj|rt AT_USER hey #dallas! ready for another great #investools income investing workshop! #
2017-02-10: rx reading: $gild quiet on m&amp;a, bayer and $jnj notch win for xarelto, $shpg faces pay-for-delay charges |$xom $amzn $googl $avgo $aapl $pfe $cvs $bac $td $wmt $cost $wfc $jnj $ge $gs $tsla $utx $f
2017-02-11: anybody see this new exec order? $vrx $agn $myl $ipxl $jnj $shak $pypl $brk $amzn $googl $ko $twtr $pep $tst $twx¡­ |AT_USER i see the point, but buying $jnj at 85 during the august '15 crash was exci
2017-02-12: mesh-related sin syndrome: a surreptitious irreversible neuralgia  #nomoremesh #fda #scotus #mdl AT_USER $jnj  |the single best investment: creating wealth with dividend growth by lowell miller:  $jnj
2017-02-13: rt AT_USER on a shopping spree, $agn bags coolsculpting tech in $2.5b buyout; $akba strikes research deal with $jnj |what should you do when you don't have a market opinion?  $brk.a $brk.b $jnj $spy $
2017-02-14: paulson goes 13g grabbing more valeant shares in q4 $vrx $agn $myl $mrk $jnj $brk $aapl $ko $pep $exel $cake $tst¡­ |mega cap stock and option trading model subscriptions available at profectus system
2017-02-15: rt AT_USER valeant's brodalumab approval proves another example of wells fargo short &amp; distort! $vrx $agn $myl $mrk $aapl $hlf $iep $b¡­|short &amp; distort or just complete incompetence again! fi
2017-02-16: valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |hurry up and grab some #johnsonjohnson before the stock bursts even more. read mo
2017-02-17: $jnj right through daily 200sma with ease, into an area of potential resistance, any pullback into the support area¡­ |johnson &amp; johnson $jnj vp paulus stoffels sells 22,000 shares |johnson &amp; 
2017-02-18: $spx spdr health care sector etf components. $bmy $gld $unh $abbv $biib $jnj $mdt $xlv $lly $pfe $celg $mrk $tmo¡­ |rt AT_USER more bullish, schwab investors are on the prowl for stocks $schw  $aapl $
2017-02-19: 02/17/17 volume leader #98 - jnj 8,691,101 johnson &amp; johnson $jnj 118.86 +0.78 +0.66% high today of 118.90 day |the most successful dividend investors ever $pep also $brk.a $abt $jnj $ko $mkc $pg 
2017-02-20: $jnj johnson &amp; johnson stock analysis -  via AT_USER #dividend #king #healthcare¡­ |rt AT_USER it does not make any sense. 3% in $jnj is a big move, 3% in $drys is a blip on the chart. as the worl
2017-02-21: AT_USER AT_USER $jnj  stock deal, also don't think it's likely but actelion all oversees cash&amp;minimal integration, so doesn't preclude|AT_USER they will get pfizered $pfe, maybe $nvs makes sense w
2017-02-22: rt AT_USER $jnj is the world's most admired drug company according to forbes, but who else made the 2017 list? |$jnj is the world's most admired drug company according to forbes, but who else made the
Answer:
Reflect on the provided data and tweets to anticipate if the closing price of $jnj is going to increase or decrease at 2017-02-23. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-08,-0.1,0.3,-0.2,-0.1,-0.1,0.1,-0.1,-0.1,0.2,0.7,0.9
2017-02-09,-0.6,0.5,-0.6,0.6,0.6,-0.4,-0.5,-0.7,-0.4,0.0,0.2
2017-02-10,-0.8,0.7,-0.9,1.0,1.0,-1.1,-1.4,-1.6,-1.4,-1.1,-0.8
2017-02-13,-0.5,0.2,-0.6,0.6,0.6,-1.3,-1.7,-2.1,-1.9,-1.6,-1.3
2017-02-14,-0.8,0.0,-0.9,0.4,0.4,-1.2,-1.8,-2.2,-2.2,-2.0,-1.7
2017-02-15,-1.1,0.2,-1.4,0.7,0.7,-1.2,-2.2,-2.7,-2.8,-2.7,-2.4
2017-02-16,-0.9,0.2,-0.9,0.8,0.8,-1.3,-2.5,-3.0,-3.4,-3.3,-3.0
2017-02-17,-0.6,0.0,-0.7,0.7,0.7,-1.3,-2.7,-3.4,-3.8,-3.8,-3.6
2017-02-21,-1.1,0.2,-1.1,0.7,0.7,-1.4,-2.9,-3.7,-4.2,-4.3,-4.2
2017-02-22,-0.2,0.2,-0.2,-0.1,-0.1,-0.7,-2.3,-3.2,-3.8,-4.0,-4.0

2017-02-08: johnson &amp; johnson $jnj position cut by orgel wealth management llc |johnson &amp; johnson $jnj position cut by orgel wealth management llc |allen investment management llc acquires 19 shares of jo
2017-02-09: #johnsonjohnson rinse-off skin care composition with cellulosic materials patented by j&amp;j. read more:  $jnj|rt AT_USER hey #dallas! ready for another great #investools income investing workshop! #
2017-02-10: rx reading: $gild quiet on m&amp;a, bayer and $jnj notch win for xarelto, $shpg faces pay-for-delay charges |$xom $amzn $googl $avgo $aapl $pfe $cvs $bac $td $wmt $cost $wfc $jnj $ge $gs $tsla $utx $f
2017-02-11: anybody see this new exec order? $vrx $agn $myl $ipxl $jnj $shak $pypl $brk $amzn $googl $ko $twtr $pep $tst $twx¡­ |AT_USER i see the point, but buying $jnj at 85 during the august '15 crash was exci
2017-02-12: mesh-related sin syndrome: a surreptitious irreversible neuralgia  #nomoremesh #fda #scotus #mdl AT_USER $jnj  |the single best investment: creating wealth with dividend growth by lowell miller:  $jnj
2017-02-13: rt AT_USER on a shopping spree, $agn bags coolsculpting tech in $2.5b buyout; $akba strikes research deal with $jnj |what should you do when you don't have a market opinion?  $brk.a $brk.b $jnj $spy $
2017-02-14: paulson goes 13g grabbing more valeant shares in q4 $vrx $agn $myl $mrk $jnj $brk $aapl $ko $pep $exel $cake $tst¡­ |mega cap stock and option trading model subscriptions available at profectus system
2017-02-15: rt AT_USER valeant's brodalumab approval proves another example of wells fargo short &amp; distort! $vrx $agn $myl $mrk $aapl $hlf $iep $b¡­|short &amp; distort or just complete incompetence again! fi
2017-02-16: valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |hurry up and grab some #johnsonjohnson before the stock bursts even more. read mo
2017-02-17: $jnj right through daily 200sma with ease, into an area of potential resistance, any pullback into the support area¡­ |johnson &amp; johnson $jnj vp paulus stoffels sells 22,000 shares |johnson &amp; 
2017-02-18: $spx spdr health care sector etf components. $bmy $gld $unh $abbv $biib $jnj $mdt $xlv $lly $pfe $celg $mrk $tmo¡­ |rt AT_USER more bullish, schwab investors are on the prowl for stocks $schw  $aapl $
2017-02-19: 02/17/17 volume leader #98 - jnj 8,691,101 johnson &amp; johnson $jnj 118.86 +0.78 +0.66% high today of 118.90 day |the most successful dividend investors ever $pep also $brk.a $abt $jnj $ko $mkc $pg 
2017-02-20: $jnj johnson &amp; johnson stock analysis -  via AT_USER #dividend #king #healthcare¡­ |rt AT_USER it does not make any sense. 3% in $jnj is a big move, 3% in $drys is a blip on the chart. as the worl
2017-02-21: AT_USER AT_USER $jnj  stock deal, also don't think it's likely but actelion all oversees cash&amp;minimal integration, so doesn't preclude|AT_USER they will get pfizered $pfe, maybe $nvs makes sense w
2017-02-22: rt AT_USER $jnj is the world's most admired drug company according to forbes, but who else made the 2017 list? |$jnj is the world's most admired drug company according to forbes, but who else made the
Answer:+Rise